A randomized, open label, two-stage, two-part, two-sequence, two-way crossover study in normal healthy adult volunteers to assess the bioequivalence of two formulations of darbepoetin alfa administered by two different routes of administration

Trial Profile

A randomized, open label, two-stage, two-part, two-sequence, two-way crossover study in normal healthy adult volunteers to assess the bioequivalence of two formulations of darbepoetin alfa administered by two different routes of administration

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Darbepoetin alfa (Primary)
  • Indications Anaemia
  • Focus Pharmacokinetics
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 07 Sep 2016 New trial record
    • 16 Aug 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top